Patients diagnosed as MASLD when present with significant fibrosis and /or deranged ALT more than upper normal limit (30IU for males & 20IU for females) more than two occasions may be diagnosed as MASH. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.